2025 Annual Report of Independent Director
Dear shareholders and shareholder representatives:
As an independent director of Shanghai Jianda Zhixin Medical Technology Group Co., Ltd. (hereinafter referred to as "the Company"), I have strictly adhered to the relevant laws and regulations, including the Company Law of the People's Republic of China, the Securities Law of the People's Republic of China, and the Management Measures for Independent Directors of Listed Companies, as well as the Company's Articles of Association and the Working Rules for Independent Directors. In my role during 2025, I diligently fulfilled my responsibilities as an independent director, attended board and shareholder meetings, and provided professional opinions and suggestions for the Company's operational decisions and compliance. I have expressed independent opinions on relevant matters of the Company, faithfully and diligently performing the role of an independent director. Below is my report on the performance of my duties in 2025:
I. Basic Information of Independent Director
(1) Personal Work Experience, Professional Background, and Concurrent Positions
Ye Qinhua, male, born in November 1981, Chinese nationality, without permanent residency abroad, certified public accountant, first expert consultant for the Ministry of Finance's Sustainable Disclosure Standards, holds a doctorate in management; previously worked at Xiamen Tianjian Huatian Accounting Firm and Xiamen Tianjian Consulting Co., Ltd.; currently co-founder and general manager of Xiamen Tianjian Caizhi Technology Co., Ltd., serving as an independent director of the Company since January 2022.
(2) Independence Statement
As an independent director of the Company, I have no relationships with the Company, its major shareholders, or actual controllers, and I do not hold any shares in the Company. My immediate family members and major social connections do not hold positions in the Company or its affiliated enterprises. In 2025, I strictly complied with the Articles of Association and the Working Rules for Independent Directors, ensuring independent and objective professional judgments on significant matters of the Company without being influenced by major shareholders or other related parties, effectively fulfilling my supervisory and decision-support responsibilities.
II. Performance of Duties in 2025
(1) Attendance at Board and Shareholder Meetings
In 2025, the Company held 5 board meetings and 3 shareholder meetings. I personally attended all board and shareholder meetings as required. The specific attendance details are as follows:
| Independent Director Name | Board Meetings | Shareholder Meetings | Required Attendance | In-Person Attendance | Attendance by Communication | Proxy Attendance | Absences | Consecutive Absences | Attendance at Shareholder Meetings |
|---|---|---|---|---|---|---|---|---|---|
| Ye Qinhua | 5 | 3 | 5 | 2 | 3 | 0 | 0 | No | 3 |
The board of directors strictly performed its duties in accordance with the Company Law, Articles of Association, and Rules of Procedure for Board Meetings. The convening and procedures of meetings complied with relevant laws and regulations, and all significant operational decisions followed the necessary procedures, ensuring legality and effectiveness. I expressed support for all proposals presented to the board in 2025, with no objections or abstentions.
(2) Attendance at Special Meetings of Independent Directors and Board Committees
In 2025, the Company held 3 meetings of the Board Audit Committee, 2 meetings of the Board Compensation and Assessment Committee, and 1 meeting of the Board Strategy Committee, with no special meetings of independent directors held. As the convener of the Board Audit Committee and a member of the Board Compensation and Assessment Committee, I strictly adhered to the working rules of the board's special committees, attending relevant meetings to provide professional opinions and advice for scientific decision-making by the board.